Keurig Dr Pepper Analyst Price Targets

Wall Street analyst price targets and consensus rating for Keurig Dr Pepper (KDP).

Price Target Range — 12 Quarters

Analyst Consensus — 21 Analysts

13Buy

8Hold

Consensus RatingBuy# Analysts21Avg. Consensus PT$36Upside to Avg. PT+18.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 15, 2026	Argus Research	Taylor Conrad	Maintained	Buy	$36
Aug 13, 2026	HSBC	Sorabh Daga	Upgrade	Hold→Buy	$40
Aug 10, 2026	Barclays	Lauren Lieberman	PT Raise	Overweight	$36→$38
Aug 7, 2026	UBS	Peter Grom	PT Raise	Buy	$38→$39
Aug 7, 2026	Evercore ISI Group	Robert Ottenstein	PT Raise	In-Line	$30→$32
Jul 23, 2026	JP Morgan	Andrea Teixeira	PT Raise	Overweight	$33→$38
Jul 16, 2026	UBS	Peter Grom	PT Raise	Buy	$34→$38
Jul 14, 2026	Citigroup	Filippo Falorni	PT Raise	Buy	$32→$37
Jun 25, 2026	Barclays	Lauren Lieberman	Upgrade	Equal-Weight→Overweight	$30→$36
Jun 12, 2026	Bernstein	Cristian Rios	Initiate	Outperform	$38
Jun 11, 2026	Bernstein	Cristian Rios	Initiate	Outperform	$38
Apr 27, 2026	Barclays	Lauren Lieberman	PT Raise	Equal-Weight	$28→$30
Apr 24, 2026	UBS	Peter Grom	PT Raise	Buy	$32→$34
Apr 24, 2026	Evercore ISI Group	Robert Ottenstein	PT Raise	In-Line	$28→$30
Apr 24, 2026	JP Morgan	Andrea Teixeira	PT Raise	Overweight	$32→$33
Apr 22, 2026	BNP Paribas	Kevin Grundy	Upgrade	Underperform→Neutral	$28
Apr 16, 2026	JP Morgan	Andrea Teixeira	PT Cut	Overweight	$36→$32
Apr 15, 2026	Citigroup	Filippo Falorni	PT Cut	Buy	$37→$32
Apr 14, 2026	Barclays	Lauren Lieberman	PT Cut	Equal-Weight	$32→$28
Apr 8, 2026	Wells Fargo	Chris Carey	PT Cut	Overweight	$40→$37

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Argus Research Reiterates Buy on Keurig Dr Pepper, Maintains $36 Price Target

Argus Research analyst Taylor Conrad reiterates Keurig Dr Pepper (NASDAQ:KDP) with a Buy and maintains $36 price target.

Benzinga Newsdesk

PRO
HSBC Upgrades Keurig Dr Pepper to Buy, Announces $40 Price Target

HSBC analyst Sorabh Daga upgrades Keurig Dr Pepper (NASDAQ:KDP) from Hold to Buy and announces $40 price target.

Benzinga Newsdesk

PRO
Barclays Maintains Overweight on Keurig Dr Pepper, Raises Price Target to $38

Barclays analyst Lauren Lieberman maintains Keurig Dr Pepper (NASDAQ:KDP) with a Overweight and raises the price target from $36 to $38.

Benzinga Newsdesk

PRO
UBS Maintains Buy on Keurig Dr Pepper, Raises Price Target to $39

UBS analyst Peter Grom maintains Keurig Dr Pepper (NASDAQ:KDP) with a Buy and raises the price target from $38 to $39.

Benzinga Newsdesk

PRO
Evercore ISI Group Maintains In-Line on Keurig Dr Pepper, Raises Price Target to $32

Evercore ISI Group analyst Robert Ottenstein maintains Keurig Dr Pepper (NASDAQ:KDP) with a In-Line and raises the price target from $30 to $32.

Benzinga Newsdesk

PRO
JP Morgan Maintains Overweight on Keurig Dr Pepper, Raises Price Target to $38

JP Morgan analyst Andrea Teixeira maintains Keurig Dr Pepper (NASDAQ:KDP) with a Overweight and raises the price target from $33 to $38.

Benzinga Newsdesk

Keurig Dr Pepper Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Keurig Dr Pepper Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Argus Research Reiterates Buy on Keurig Dr Pepper, Maintains $36 Price Target

PRO
HSBC Upgrades Keurig Dr Pepper to Buy, Announces $40 Price Target

PRO
Barclays Maintains Overweight on Keurig Dr Pepper, Raises Price Target to $38

PRO
UBS Maintains Buy on Keurig Dr Pepper, Raises Price Target to $39

PRO
Evercore ISI Group Maintains In-Line on Keurig Dr Pepper, Raises Price Target to $32

PRO
JP Morgan Maintains Overweight on Keurig Dr Pepper, Raises Price Target to $38

People Also Watch

People Also Watch

Keurig Dr Pepper Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Keurig Dr Pepper Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROArgus Research Reiterates Buy on Keurig Dr Pepper, Maintains $36 Price Target

PROHSBC Upgrades Keurig Dr Pepper to Buy, Announces $40 Price Target

PROBarclays Maintains Overweight on Keurig Dr Pepper, Raises Price Target to $38

PROUBS Maintains Buy on Keurig Dr Pepper, Raises Price Target to $39

PROEvercore ISI Group Maintains In-Line on Keurig Dr Pepper, Raises Price Target to $32

PROJP Morgan Maintains Overweight on Keurig Dr Pepper, Raises Price Target to $38

People Also Watch

People Also Watch

PRO
Argus Research Reiterates Buy on Keurig Dr Pepper, Maintains $36 Price Target

PRO
HSBC Upgrades Keurig Dr Pepper to Buy, Announces $40 Price Target

PRO
Barclays Maintains Overweight on Keurig Dr Pepper, Raises Price Target to $38

PRO
UBS Maintains Buy on Keurig Dr Pepper, Raises Price Target to $39

PRO
Evercore ISI Group Maintains In-Line on Keurig Dr Pepper, Raises Price Target to $32

PRO
JP Morgan Maintains Overweight on Keurig Dr Pepper, Raises Price Target to $38